Serina Therapeutics, Inc.
AMEXSER short interest drops 25.7% in one week to 2.88% of float, while cost to borrow falls sharply to 52.4% from 75.7% a week prior.
Snapshot as of 29 Jun 2026
No long-form analysis yet for SER. Pulse alerts and the live data picture are available on ORTEX.
Open SER on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SER — free to start on ORTEX.
Sign up for free →Open SER on ORTEX